SAN FRANCISCO, Jan. 20, 2026 /PRNewswire/ — Katalyze AI today announced the launch of Katalyst, an AI agent purpose-built for pharmaceutical manufacturing. Designed for GxP-regulated environments, Katalyst helps manufacturing teams reduce repetitive manual work, accelerate scientific decision-making, and operate with traceable, audit-ready insights grounded in validated production data.
Katalyst is designed to support scientists, process engineers, and quality analysts directly on the manufacturing shop floor by continuously analyzing production data and translating it into actionable insights.
It connects to the operational systems manufacturers already rely on, including Manufacturing Execution Systems (MES), Quality Management Systems (QMS), and Laboratory Information Management Systems (LIMS).
By operating within existing production environments, the agent enables teams to begin using AI-driven decision support without lengthy implementation cycles or manual data preparation.
Once deployed, Katalyst analyzes manufacturing production equipment, processes, and raw material data. The agent understands how process parameters and material characteristics influence performance, generates scientific reports and publishes insights directly to users.
The outputs combine statistical analysis, advanced data visualizations, and scientifically grounded reasoning informed by industry expertise.
Teams can further explore findings, ask follow-up questions, and trigger additional analytical steps through the built-in AI assistant. In parallel, the agent delivers always-on process monitoring to identify early signals of process drift or potential batch failures before they occur.
Early adopters have reported up to 10% improvements in yield and 20–30% reductions in batch failures.
“Katalyst helps teams solve engineering problems faster by reducing manual analysis and supporting scientifically reliable decision-making directly within production environments,” said Reza Farahani, CEO of Katalyze AI.
“With Katalyst, we are introducing an AI agent grounded in the scientific principles manufacturing teams rely on to ensure consistency and quality,” said Hannes Bretschneider, PhD, Chief AI Officer at Katalyze AI. “Its outputs are source-grounded, traceable, and reproducible – characteristics essential for any system operating in regulated environments.”
Read the full press release: https://katalyzeai.com/newsroom/katalyze-ai-launches-katalyst
About Katalyze AI
Katalyze AI builds Agentic AI systems for pharmaceutical manufacturing to improve yield, quality, and operational reliability. The company delivers AI agents that integrate with existing data infrastructure and supports end-to-end intelligence across laboratory, manufacturing, and quality operations. Visit katalyzeai.com to learn more.
SOURCE Katalyze AI
LEHI, Utah, Jan. 24, 2026 /PRNewswire/ -- Gargle, Inc., a premier dental marketing partner, officially…
Black Book Market Research announces an independent, decision grade companion report available gratis to global…
Prestigious designation recognizes excellence in nursing, patient care, and clinical outcomesLAS VEGAS, Jan. 24, 2026…
A consumer-focused examination of NAD+ injections, NAD+ supplements, NAD+ peptides, NAD+ dosage protocols, documented NAD+…
DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today…
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company”…